276 related articles for article (PubMed ID: 23747143)
1. Bone density in heart or lung transplant recipients--a longitudinal study.
Wang TK; O'Sullivan S; Gamble GD; Ruygrok PN
Transplant Proc; 2013; 45(6):2357-65. PubMed ID: 23747143
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
[TBL] [Abstract][Full Text] [Related]
4. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
5. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
[TBL] [Abstract][Full Text] [Related]
6. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
7. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
9. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
10. Prevention of bone loss and fracture after lung transplantation: a pilot study.
Cahill BC; O'Rourke MK; Parker S; Stringham JC; Karwande SV; Knecht TP
Transplantation; 2001 Oct; 72(7):1251-5. PubMed ID: 11602851
[TBL] [Abstract][Full Text] [Related]
11. No association between BMD and prevalent vertebral fractures in liver transplant recipients at time of screening before transplantation.
Krol CG; Dekkers OM; Kroon HM; Rabelink TJ; van Hoek B; Hamdy NA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3677-85. PubMed ID: 25057874
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation.
Grotz WH; Mundinger FA; Gugel B; Exner VM; Kirste G; Schollmeyer PJ
Transplantation; 1995 Apr; 59(7):982-6. PubMed ID: 7709459
[TBL] [Abstract][Full Text] [Related]
13. Decreased bone mineral density is common after autologous blood or marrow transplantation.
Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss.
Buchs N; Helg C; Collao C; Chapuis B; Slosman D; Bonjour JP; Rizzoli R
Osteoporos Int; 2001; 12(10):880-6. PubMed ID: 11716193
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis in lung transplant candidates compared to matched healthy controls.
Lakey WC; Spratt S; Vinson EN; Gesty-Palmer D; Weber T; Palmer S
Clin Transplant; 2011; 25(3):426-35. PubMed ID: 20482557
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density.
Shin CS; Choi HJ; Kim MJ; Kim JT; Yu SH; Koo BK; Cho HY; Cho SW; Kim SW; Park YJ; Jang HC; Kim SY; Cho NH
Bone; 2010 Aug; 47(2):378-87. PubMed ID: 20362081
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for changes in bone mineral density and the effect of antiosteoporosis management after renal transplantation.
Ahn HJ; Kim HJ; Kim YS; Kim MS; Huh KH; Kim JH; Lee JH; Jeon KO; Kim SI
Transplant Proc; 2006 Sep; 38(7):2074-6. PubMed ID: 16980003
[TBL] [Abstract][Full Text] [Related]
18. Systemic mastocytosis and bone involvement in a cohort of 75 patients.
Barete S; Assous N; de Gennes C; Grandpeix C; Feger F; Palmerini F; Dubreuil P; Arock M; Roux C; Launay JM; Fraitag S; Canioni D; Billemont B; Suarez F; Lanternier F; Lortholary O; Hermine O; Francès C
Ann Rheum Dis; 2010 Oct; 69(10):1838-41. PubMed ID: 20570833
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
20. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J
BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
